Report Archive
All Research
Page 14 of 43 · 1027 reports
50/100
Nintendo (7974.T / NTDOY) Zen Horizon Framework Deep Research
Nintendo is one of the world's strongest gaming IP empires, founded in Kyoto in 1889 as a hanafuda card maker and later becoming one of the three global console pillars alongside Sony PlayStation and Microsoft Xbox after the NES became a worldwide hit in 1985. Its core business is Switch 2 hardware plus first-party software, which together account for 85% of revenue, alongside smartphone games, Switch Online subscriptions, Nintendo films, USJ theme parks, and IP licensing. Research rating Buy: a durable IP moat, cash-generative platform economics, and a conservative FY2027 guide leave meaningful upside from a depressed valuation.
50/100
MediaTek (2454.TW) Zen Horizon Framework Deep-Dive Research
MediaTek is the world's second-largest fabless chip designer after Qualcomm and ranked among the global top ten semiconductor companies by 2025 revenue, with a business mix spanning mobile chips, smart edge platforms, and an emerging AI ASIC franchise. The central investment debate is whether the 2026 AI ASIC revenue target, doubled from USD 1 billion to USD 2 billion, can justify a valuation that already prices in a major 2027-2028 breakout despite FY2025 net income declining 1.0%. Research rating Watch: a strong strategic option in AI ASICs, but current valuation leaves little margin of safety.
45/100
iFLYTEK (002230.SHE) Zen Horizon Research Report
iFLYTEK is China's leading integrated AI voice, foundation-model, education, government, healthcare, and automotive player, and the only listed pure AI full-stack company in the A-share market. FY2025 revenue reached RMB 27.105 billion (+16.12%), net profit attributable to shareholders was RMB 839 million (+49.85%), non-GAAP recurring net profit was RMB 264 million (+40.47%), overseas revenue surged 275%, and R&D spending reached RMB 5.364 billion, or 19.79% of revenue; Q1 2026 revenue was RMB 5.274 billion (+13.23%), but the recurring loss widened to RMB -430 million. Rating Watch: Spark V4.0 to X1 to X2, fully domestic compute training, strong overseas momentum, two U.S. Entity List events in 2019 and 2023, and founder Qingfeng Liu's 20.82% aggregate control make this a high-quality but fully priced AI theme stock.
35/100
Samsung SDI (006400.KO) Zen Horizon Research Report
Samsung SDI is South Korea's largest integrated battery company and one of the world's top five lithium battery makers by cumulative installations, with Energy Solutions contributing about 93% of revenue and Electronic Materials about 7%. FY2025 revenue was KRW 13.27 trillion (-21%), with an operating loss of KRW 1.72 trillion and a net loss of KRW 64.9 billion; Q1 2026 revenue rebounded to KRW 3.58 trillion (+12.6%), operating loss narrowed by 64.2%, and net income turned positive at KRW 56.1 billion, but its global EV battery share fell out of the top 10. Research rating Watch: the turnaround signals are visible, but valuation already prices in recovery while dilution, JV delays, and market-share erosion remain unresolved.
46/100
Rocket Lab (RKLB) Zen Horizon Research Report
Rocket Lab is the second-largest listed commercial space player after SpaceX, with a vertically integrated stack spanning rocket design, launch, satellites, and payloads. The core thesis rests on Electron small launchers, about 30% of launch services with 21 launches and a 100% success rate in FY2025, plus Space Systems at about 70%, including the SDA USD 816 million 18-satellite contract and the USD 275 million Geost acquisition that moves the company into military payloads. Research rating Watch: FY2025 revenue reached USD 602 million, backlog rose to USD 1.85 billion, and Q1 2026 revenue reached USD 200 million, but the delayed Neutron medium-lift rocket, now pushed to Q4 2026, remains the key valuation turning point.
47/100
Cameco (CCJ.US / CCO.TO) Zen Horizon Research Report
Cameco is the largest uranium producer in the Western world, with roughly 18% global share, and owns a strategic 49% stake in Westinghouse, the leading U.S. nuclear equipment company. The core thesis is a full nuclear-fuel-cycle position spanning upstream uranium mining, midstream conversion, and downstream reactor OEM exposure, supported by FY2024 revenue of CAD 3.14 billion, adjusted EBITDA of CAD 1.395 billion, and Q1 2026 net income growth of 87%. Report rating Watch: a high-quality nuclear-cycle asset, but the current price already embeds optimistic assumptions for uranium, Westinghouse, and SMR optionality.
46/100
Subsea 7 (SUBC.OL) Zen Horizon Research Report
Subsea 7 is one of the two global leaders in subsea oil and gas engineering and services, designing, installing, connecting, and maintaining full subsea infrastructure systems for deepwater oil and gas fields and offshore wind farms. The core thesis is a structurally stronger margin profile, USD 13.5 billion of backlog at the end of Q1 2026, and a pending 50/50 merger with Saipem to form Saipem7, expected to close in H2 2026. Report rating Watch: a high-quality cyclical compounder with a merger catalyst, but the current NOK 332.6 price already embeds optimistic execution and leaves limited downside protection.
U.S. Market Daily Close｜2026-06-08
An oversold bounce in chip stocks held up the Nasdaq and S&P 500, but the Dow finished lower and breadth was uneven, leaving the market in sector-rotation mode ahead of CPI. The bounce was concentrated in beaten-down AI and semiconductor names rather than a broad-based advance, with rates and oil still applying pressure. Rating Watch: a single-day chip rebound looks more like a technical repair after last Friday's selloff than a fresh trend confirmation, so wait for breadth, rates, and oil to align.
47/100
Novonesis A/S (NSIS-B.CO) Zen Horizon Research Report
Novonesis A/S (NSIS-B.CO) is a Copenhagen-listed Danish biotechnology platform leader formed in January 2024 through the merger of Novozymes, the global leader in industrial enzymes, and Chr. Hansen, the global leader in probiotics, with FY2025 revenue of DKK 32,376M and an adjusted EBITDA margin of 37.1%. Its two divisions span Food & Health, built around probiotics, enzymes, and the microbiome, and Planetary Health, built around industrial enzymes, feed, and agricultural biosolutions, while Novo Holdings controls 25.5% of the economics and 63.35% of the votes. Research rating Watch: a high-quality compounder with merger synergies already delivered, but the current valuation is near the upper end of fair value and leaves limited margin of safety against EUR/USD pressure and integration risk.
48/100
Lattice Semiconductor (LSCC.US) Zen Horizon Research Report
Lattice Semiconductor (LSCC.US) is now the world’s only major independent FPGA leader after AMD acquired Xilinx in 2022 and Intel separated Altera in 2025, with a focus on low-power FPGA for Edge AI, communications and computing, industrial, and automotive safety applications. FY2025 revenue was $523.3M at the inventory-cycle trough, non-GAAP EPS was $1.05, and Q1 2026 revenue reached a record $170.9M, up 42% YoY, while new CEO Ford Tamer, former Inphi CEO for 9 years, is pushing incremental growth in Edge AI and data centers. Research rating Watch: at $142.15, a $19.5B market cap, 74x forward PE, and a 52-week gain of +198%, valuation has already discounted a near-perfect scenario.
45/100
Givaudan SA (GIVN.SW) Zen Horizon Research Report
Givaudan SA (GIVN.SW), headquartered in Geneva and tracing its roots to 1768, is the global leader in flavors and fragrances, with FY2025 revenue of CHF 7,472M, comparable EBITDA margin of 24.2%, and net income of CHF 1,071M. Its two-pillar Fragrance & Beauty plus Taste & Wellbeing business holds roughly 25% global share, while the oligopoly with IFF, Firmenich, and Symrise controls at least 53% of the market, but the key variables are the CEO handover after a 20-year tenure and the Q1 2026 slowdown in Taste. Research rating Watch: a high-quality GDP-plus compounder, but the current price already prices in much of the quality while the CEO transition and Taste deceleration still need evidence.
51/100
Eurofins Scientific (Eurofins Scientific SE, ERF.PA) — Zen Horizon Report
Eurofins Scientific, founded in 1987 by Gilles Martin in Nantes, France and headquartered in Luxembourg, is the world's largest testing, inspection and certification (TIC) leader, spanning food, environment, pharma, clinical diagnostics and consumer products, with roughly 64,000 employees and 900+ laboratories across 50+ countries; FY2025 revenue was EUR 7.30 B (+5.0% reported / +4.1% organic), adjusted EBITDA margin 22.5% (mature business 24.3%) and EPS EUR 2.31 (+24%), while the Martin family holds 32.9% economic interest / 65.8% voting power through Analytical Bioventures. Following Muddy Waters' June 2024 short report alleging self-dealing—which the company fully rebutted—the market's governance discount has yet to fully clear. Rating Watch: a high-quality TIC leader that is reasonably-to-richly valued and awaits a pullback rather than entry at the current price.
45/100
Renishaw plc (RSW.LSE) Zen Horizon Research Report
Renishaw is a Gloucestershire, UK-based precision metrology and industrial automation leader founded in 1973 by two former Rolls-Royce engineers, the original inventor and global No. 1 standard-setter in coordinate measuring machine (CMM) touch-trigger probes, with 94% of revenue from manufacturing technologies and 6% from analytical instruments and medical devices. FY2025 revenue was £713M, adjusted operating margin was 15.7%, adjusted profit before tax was £127.2M, and FY2026 H1 accelerated to +11.5% at constant currency on structural semiconductor and defense demand; after founder Sir David McMurtry died in December 2024, the McMurtry/Deer families formed Deltam Holdings in 2025 with a 50.25% stake, completing generational succession and ending the sale process. Research rating Watch: a high-quality UK hidden champion whose valuation already discounts much of the 20% margin and semiconductor-defense supercycle upside.
44/100
Vestas Wind Systems A/S (VWS.CO) Zen Horizon Research Report
Vestas Wind Systems A/S is the global No. 1 wind turbine OEM outside China, headquartered in Aarhus, Denmark, founded in 1898 and manufacturing wind turbines since 1979; 2025 revenue was EUR 18.8 B, with Power Solutions contributing 81% through onshore and offshore turbine sales and Service contributing 19% through 15-25 year long-term O&M contracts. Its 192 GW cumulative installed base equals 23% of global wind capacity, placing it in the top-three structure alongside China's Goldwind and Siemens Gamesa, while margins have recovered from -7.6% to +5.7% after the 2021-2024 supply-chain, inflation, and offshore-quality crisis, with management targeting an EBIT margin of at least 10% by 2030. Research rating Cautious Buy: a high-quality wind OEM with a Service annuity moat and a clear long-term margin-recovery path, but position building should be staged given policy and execution risks.
48/100
Lonza Group AG (LONN.SW) Zen Horizon Research Report
Lonza Group is a Basel-based Swiss biopharmaceutical CDMO founded in 1897 and now the world's second-largest biologics manufacturing outsourcer, with 2025 revenue of CHF 6.53B split between Biologics (70%, mAb / ADC / CGT / mRNA manufacturing) and Capsules & Health Ingredients (30%). The core thesis is that its 2024 strategic reset, including the USD 1.2B acquisition of Roche's Vacaville site in California, the divestiture of Specialty Ingredients, and the arrival of CEO Wolfgang Wienand, positions Lonza as one of only two scaled mammalian biologics capacity leaders above 200,000L, alongside Samsung Biologics, with additional policy tailwinds from the BIOSECURE Act against WuXi Biologics. Rating Hold: a high-quality CDMO compounder with visible recovery and upside catalysts, but a thin margin of safety at the current price.
51/100
Safran SA (SAF.PA) — Zen Horizon Report
Safran is France's leading narrowbody aero-engine champion, co-owning CFM International 50/50 with GE Aerospace (the CFM56/LEAP family powers the Boeing 737 MAX and Airbus A320neo, with roughly 75% share including the JV); 2025 revenue was €31.2B, split 78% civil aviation and 22% defense, with the aftermarket annuity (23,000 CFM56 plus 7,500 LEAP units in service) at the core of profit; defense has lately accelerated on France's LPM 2024-2030 act, and the CFM partnership with GE was renegotiated in 2025 to run through 2050. Rating Watch: a high-quality narrowbody-aftermarket annuity asset whose current price already fully discounts the roadmap, leaving thin margin of safety for new positions.
34/100
NuScale Power (SMR): Zen Horizon Research Report
NuScale Power is the world's first small modular reactor (SMR) pure-play to win a U.S. NRC-approved design certification, spun out of Oregon State University's IRIS project in 2007 and listed via SPAC in 2022; each SMR module is rated at 77 MWe and a typical multi-module plant runs 924 MWe. But the early-2024 cancellation of its flagship CFPP/UAMPS project gutted the commercial outlook, with TTM revenue of just $18.7M, Q1 revenue down 95.8% year over year, an operating margin of -101%, and a commercial deployment window no earlier than the 2030s. At the current $10.50 share price (down 70% over the past year), the implied 195x P/S still leaves valuation badly overextended. Rating Avoid: a compelling story is not a good investment, and the gap between narrative and fundamentals has reached an unsustainable level.
46/100
Novartis (NVS) Zen Horizon Research Report
Novartis is one of the world's top ten innovative pharmaceutical companies, headquartered in Basel, Switzerland, and has repositioned itself as a pure-play innovative medicines company after spinning off Sandoz in October 2023. Its portfolio spans cardiovascular, oncology, immunology, neuroscience, and rare diseases, supported by 2025 revenue of about $56.6 billion, a 30% operating margin, roughly $15 billion in free cash flow, and 28 consecutive years of dividend increases, while Entresto's U.S. generic entry in Q4 2025 remains the key near-term challenge. Research rating Hold: a high-quality defensive compounder with a deep moat, but the current price already reflects neutral expectations and leaves limited margin of safety.
44/100
Quanta (2382.TW) Zen Horizon Research Report
Quanta Computer, founded by Barry Lam in 1988, is the world's largest notebook ODM and has transformed in recent years into the world's second-largest AI server rack-scale ODM, behind only Foxconn, manufacturing NVIDIA GB200/GB300 systems for customers including Google, Meta, and AWS. In 2026Q1, servers accounted for more than 80% of revenue, revenue grew 66.6% year over year, and quarterly gross margin fell to 4.78%. Research rating Hold: a genuine AI infrastructure compounder, but margin quality, cash flow pressure, and valuation leave too little margin of safety at the current price.
48/100
Rolls-Royce (RR.LSE) Zen Horizon Research Report
Rolls-Royce is a UK national-champion industrial group spanning aero engines, marine power, power systems, and nuclear power, including civilian SMRs and military submarine propulsion. After its share price fell to 70p in 2022 and the company approached distress, new CEO Tufan Erginbilgiç launched the aggressive "burning platform" restructuring in early 2023, driving the share price to 1260p within three years, an 18-fold rise. Research rating Hold: a high-quality turnaround and strategic nuclear option, but the current valuation has already priced in most of the good news.
46/100
nVent Electric (NVT) Zen Horizon Research Report
nVent is an electrical infrastructure supplier spun out of Pentair in 2018, with core businesses in data-center IT racks, liquid-cooling CDU/RDHx systems, modular data-center buildings through Trachte, and medium- and low-voltage switchgear through Avail EPG. The core thesis is that nVent has recycled capital out of mature thermal-management assets and into AI data-center picks and shovels, with fiscal 2024 revenue of about $3.35 billion and an operating margin near 20%. Report rating Hold: a high-quality compounder, but the current valuation already prices in most of the AI data-center upside.
37/100
Oklo (OKLO.US) Zen Horizon Research Report
Oklo is an advanced nuclear fission developer founded in 2013 by two MIT nuclear engineering PhDs and taken public on the NYSE in 2024 through Sam Altman's SPAC, with its sodium-cooled fast reactor Aurora (75 MWe) and a build-own-operate model that sells power rather than reactors to AI data centers under long-term PPAs. The core thesis is real policy access and real cash, but a pre-revenue company with a Q1 2026 net loss of $33M, $2.54B of cash, and DOE reactor-pilot selection is already carrying a very long-dated option value. Report Rating Watch: an excellent story with no margin of safety at the current price.
39/100
Navitas Semiconductor (NVTS.US) Zen Horizon Research Report
Navitas (NVTS) is a small fabless wide-bandgap power semiconductor company founded in California in 2014, listed via SPAC in 2021, and expanded into high-voltage SiC through the $100M GeneSiC acquisition in 2022. Its two product lines, GaNFast integrated ICs and GeneSiC SiC MOSFETs, span 80V to 3300V and target AI data-center 800V HVDC, energy infrastructure, high-performance computing, industrial electrification, and mobile charging. Report rating Underweight: NVIDIA's 800V HVDC partnership is real, but the valuation already prices in an optimistic Kyber 2027 ramp, dominant NVTS share, and an AI narrative premium.
49/100
Hesai Group (HSAI) Zen Horizon Research Report
Hesai Group is the global leader in automotive lidar, founded in Shanghai in 2014, listed on Nasdaq in 2023, and dual-primary listed in Hong Kong in 2025. As a pure-play lidar hardware supplier, its products span ADAS factory installation, Robotaxi/L4, and robotics, with customers including 40 auto brands and most of the world's leading Robotaxi companies. Research rating Watch: 2025 shipments reached 1.62 million units, revenue was about $433 million, or roughly RMB3.0 billion, and Hesai became the world's first lidar company to deliver full-year GAAP profitability, yet weak earnings quality, slowing growth, and binary U.S. regulatory tail risk keep the stock below a Buy threshold.